AUTONOMIX MEDICAL INC (AMIX) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:AMIX • US05330T2050

0.398 USD
0 (-0.5%)
At close: Jan 30, 2026
0.3943 USD
0 (-0.93%)
After Hours: 1/30/2026, 8:00:00 PM
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to AMIX. AMIX was compared to 184 industry peers in the Health Care Equipment & Supplies industry. AMIX has a great financial health rating, but its profitability evaluates not so good. AMIX does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • In the past year AMIX has reported negative net income.
  • AMIX had a negative operating cash flow in the past year.
AMIX Yearly Net Income VS EBIT VS OCF VS FCFAMIX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 2025 -5M -10M -15M

1.2 Ratios

  • AMIX has a Return On Assets of -210.43%. This is amonst the worse of the industry: AMIX underperforms 90.76% of its industry peers.
  • AMIX has a worse Return On Equity (-258.98%) than 75.00% of its industry peers.
Industry RankSector Rank
ROA -210.43%
ROE -258.98%
ROIC N/A
ROA(3y)-170.19%
ROA(5y)N/A
ROE(3y)-217.4%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
AMIX Yearly ROA, ROE, ROICAMIX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 2025 -200 -400 -600

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for AMIX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
AMIX Yearly Profit, Operating, Gross MarginsAMIX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 2025

7

2. Health

2.1 Basic Checks

  • Compared to 1 year ago, AMIX has more shares outstanding
  • AMIX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
AMIX Yearly Shares OutstandingAMIX Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 2025 5M 10M 15M 20M
AMIX Yearly Total Debt VS Total AssetsAMIX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 2025 2M 4M 6M 8M

2.2 Solvency

  • Based on the Altman-Z score of -15.77, we must say that AMIX is in the distress zone and has some risk of bankruptcy.
  • AMIX has a Altman-Z score of -15.77. This is amonst the worse of the industry: AMIX underperforms 84.24% of its industry peers.
  • AMIX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -15.77
ROIC/WACCN/A
WACCN/A
AMIX Yearly LT Debt VS Equity VS FCFAMIX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 2025 0 5M -5M

2.3 Liquidity

  • AMIX has a Current Ratio of 5.31. This indicates that AMIX is financially healthy and has no problem in meeting its short term obligations.
  • AMIX's Current ratio of 5.31 is amongst the best of the industry. AMIX outperforms 81.52% of its industry peers.
  • A Quick Ratio of 5.31 indicates that AMIX has no problem at all paying its short term obligations.
  • AMIX has a better Quick ratio (5.31) than 83.70% of its industry peers.
Industry RankSector Rank
Current Ratio 5.31
Quick Ratio 5.31
AMIX Yearly Current Assets VS Current LiabilitesAMIX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 2025 2M 4M 6M 8M

0

3. Growth

3.1 Past

  • AMIX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 63.77%, which is quite impressive.
EPS 1Y (TTM)63.77%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%44.13%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • Based on estimates for the next years, AMIX will show a very negative growth in Earnings Per Share. The EPS will decrease by -12.65% on average per year.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-77.46%
EPS Next 2Y-11.01%
EPS Next 3Y-12.65%
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
AMIX Yearly Revenue VS EstimatesAMIX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2028 200K 400K 600K 800K
AMIX Yearly EPS VS EstimatesAMIX Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 2028 -0.5 -1 -1.5 -2 -2.5

0

4. Valuation

4.1 Price/Earnings Ratio

  • AMIX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year AMIX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AMIX Price Earnings VS Forward Price EarningsAMIX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AMIX Per share dataAMIX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -2 -4

4.3 Compensation for Growth

  • A cheap valuation may be justified as AMIX's earnings are expected to decrease with -12.65% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-11.01%
EPS Next 3Y-12.65%

0

5. Dividend

5.1 Amount

  • AMIX does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

AUTONOMIX MEDICAL INC / AMIX FAQ

Can you provide the ChartMill fundamental rating for AUTONOMIX MEDICAL INC?

ChartMill assigns a fundamental rating of 2 / 10 to AMIX.


What is the valuation status for AMIX stock?

ChartMill assigns a valuation rating of 0 / 10 to AUTONOMIX MEDICAL INC (AMIX). This can be considered as Overvalued.


How profitable is AUTONOMIX MEDICAL INC (AMIX) stock?

AUTONOMIX MEDICAL INC (AMIX) has a profitability rating of 0 / 10.


How financially healthy is AUTONOMIX MEDICAL INC?

The financial health rating of AUTONOMIX MEDICAL INC (AMIX) is 7 / 10.


Can you provide the expected EPS growth for AMIX stock?

The Earnings per Share (EPS) of AUTONOMIX MEDICAL INC (AMIX) is expected to decline by -77.46% in the next year.